BLADDER ADENOCARCINOMA STAGE UNSPECIFIED

BLADDER ADENOCARCINOMA STAGE UNSPECIFIED was reported 47 times

BLADDER ADENOCARCINOMA STAGE UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Glinide [EPC] 2 0.0002
1 Non-Standardized Plant Allergenic Extract [EPC] 2 0.0001
2 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2 0.0001
3 Cholinesterase Inhibitor [EPC] 1 0.0001
4 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
5 Serotonin Reuptake Inhibitor [EPC] 4 0.0000
6 Typical Antipsychotic [EPC] 1 0.0000
7 Angiotensin Converting Enzyme Inhibitor [EPC] 5 0.0000
8 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2 0.0000
9 Sulfonylurea [EPC] 4 0.0000
10 Interleukin-6 Receptor Antagonist [EPC] 4 0.0000
11 Androgen Receptor Inhibitor [EPC] 2 0.0000
12 Non-Standardized Food Allergenic Extract [EPC] 2 0.0000
13 Polyene Antifungal [EPC] 1 0.0000
14 Nucleoside Analog Antiviral [EPC] 2 0.0000
15 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
16 General Anesthetic [EPC] 1 0.0000
17 Platelet Aggregation Inhibitor [EPC] 9 0.0000
18 Azole Antifungal [EPC] 2 0.0000
19 HMG-CoA Reductase Inhibitor [EPC] 4 0.0000
20 Purine Antimetabolite [EPC] 1 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
23 Aromatase Inhibitor [EPC] 1 0.0000
24 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
25 CD20-directed Cytolytic Antibody [EPC] 2 0.0000
26 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
27 Microtubule Inhibitor [EPC] 1 0.0000
28 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 3 0.0000
30 Thiazide Diuretic [EPC] 1 0.0000
31 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
32 Platinum-based Drug [EPC] 1 0.0000
33 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
34 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
35 Corticosteroid [EPC] 4 0.0000
36 Vitamin C [EPC] 1 0.0000
37 GLP-1 Receptor Agonist [EPC] 1 0.0000
38 Insulin Analog [EPC] 1 0.0000
39 Loop Diuretic [EPC] 1 0.0000
40 Thalidomide Analog [EPC] 1 0.0000
41 Kinase Inhibitor [EPC] 1 0.0000
42 Tumor Necrosis Factor Blocker [EPC] 1 0.0000